GMED (STOCKS)
GLOBUS MEDICAL INC
$87.220000
-1.040000 (-1.18%)
Prev close: $88.260000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Keith W. Pfeil
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $11,740.29M
- Employees
- 5,300
- P/E (TTM)
- 28.52
- P/B (TTM)
- 2.70
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
12
Buy
6
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$1.18 | $0.80 | +0.3816 | +47.80% |
|
Jun 2025 (Q2)
|
$0.86 | $0.77 | +0.0894 | +11.60% |
|
Mar 2025 (Q1)
|
$0.68 | $0.76 | -0.0789 | -10.40% |
|
Dec 2024 (Q4)
|
$0.84 | $0.76 | +0.0797 | +10.48% |
Financial Statements
| Revenues | $2.77B |
| Benefits Costs and Expenses | $2.31B |
| Cost Of Revenue | $960.13M |
| Costs And Expenses | $2.31B |
| Gross Profit | $1.81B |
| Nonoperating Income/Loss | $89.75M |
| Operating Expenses | $1.44B |
| Selling, General, and Administrative Expenses | $1.11B |
| Research and Development | $144.49M |
| Other Operating Expenses | $181.56M |
| Operating Income/Loss | $370.75M |
| Income/Loss From Continuing Operations After Tax | $423.78M |
| Income/Loss From Continuing Operations Before Tax | $460.50M |
| Income Tax Expense/Benefit | $36.72M |
| Interest Income/Expense After Provision For Losses | $4.64M |
| Interest Income/Expense Operating, Net | $4.64M |
| Net Income/Loss | $423.78M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $423.78M |
| Net Income/Loss Available To Common Stockholders, Basic | $423.78M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Provision For Loan, Lease, And Other Losses | $0.00 |
| Basic Earnings Per Share | $3.13 |
| Diluted Earnings Per Share | $3.09 |
| Basic Average Shares | 270,819,000 |
| Diluted Average Shares | 274,149,000 |
| Assets | $5.10B |
| Current Assets | $1.92B |
| Inventory | $771.54M |
| Other Current Assets | $1.15B |
| Noncurrent Assets | $3.17B |
| Fixed Assets | $577.79M |
| Intangible Assets | $773.90M |
| Other Non-current Assets | $1.82B |
| Liabilities | $696.82M |
| Current Liabilities | $465.96M |
| Accounts Payable | $87.23M |
| Wages | $157.06M |
| Other Current Liabilities | $221.68M |
| Noncurrent Liabilities | $230.86M |
| Equity | $4.40B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $4.40B |
| Liabilities And Equity | $5.10B |
| Net Cash Flow From Operating Activities | $715.20M |
| Net Cash Flow From Operating Activities, Continuing | $715.20M |
| Net Cash Flow From Investing Activities | -$347.69M |
| Net Cash Flow From Investing Activities, Continuing | -$347.69M |
| Net Cash Flow From Financing Activities | -$632.64M |
| Net Cash Flow From Financing Activities, Continuing | -$632.64M |
| Exchange Gains/Losses | $14.13M |
| Net Cash Flow | -$251.00M |
| Net Cash Flow, Continuing | -$265.13M |
| Comprehensive Income/Loss | $441.67M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $441.67M |
| Other Comprehensive Income/Loss | $441.67M |
| Other Comprehensive Income/Loss Attributable To Parent | $17.89M |